Premium
The systems for monitoring adverse drug reactions in Hong Kong
Author(s) -
Chan Thomas Y. K.,
Critchley Julian A. J. H.
Publication year - 1993
Publication title -
pharmacoepidemiology and drug safety
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.023
H-Index - 96
eISSN - 1099-1557
pISSN - 1053-8569
DOI - 10.1002/pds.2630020209
Subject(s) - medicine , pharmacoepidemiology , postmarketing surveillance , pharmacovigilance , adverse drug reaction , drug reaction , medical emergency , family medicine , drug , emergency medicine , adverse effect , pharmacology , medical prescription
Post‐marketing surveillance is essential for providing additional safety information on drugs. In Hong Kong, a scheme to monitor ADRs was introduced in October 1986. It relies on voluntary reporting by hospital doctors and general practitioners of suspected ADRs. There appeared to be gross under‐reporting as only 68 reports were received between 1986 to 1991. Although hospital‐based studies have provided us with information on the pattern of and the risk factors for ADRs, spontaneous reporting on a national scale remains the only feasible and inexpensive method for monitoring ADRs. In order to increase reporting, we hope to convince the medical profession in Hong Kong of the importance in reporting ADRs and to make it easier for them to report.